MiMedx Group Completes $5,000,000 Private Placement

KENNESAW, Ga., Dec. 28, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that the Company's $5,000,000 private placement offering to sell convertible notes and warrants has been fully subscribed. Through the offering, which commenced on October 15, 2011, the Company received $5,000,000 in proceeds and issued 5% Co...continued MDXG  Orthopedic Prosthetic Healthcare

URL: http://www.investorpoint.com/news/IPONEWS1/47169410/